We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
ER alpha selective chromone, isoxazolylchromones, induces ROS‐mediated cell death without autophagy.
- Authors
Kaushik, Swati; Sanawar, Rahul; Lekshmi, Asha; Chandrasekhar, Leena; Nair, Mydhily; Bhatnagar, Seema; Santhoshkumar, Thankayyan Retnabai
- Abstract
Chromones are recognized as privileged structures and useful templates for the design of novel compounds with promising pharmacological activity. Several reports implicate chromone scaffold as an antitumor agent. The present study highlights synthesis, docking, and potential activity of isoxazolylchromones, 3(a–f), a new class of compounds as potential agents exhibiting ERα antagonism and ERβ agonism. Molecular docking studies determined the binding site of compounds 3(a–f) in ERα and ERβ. All the analogues synthesized showed preferential cytotoxicity in ERα+ cell line (MCF‐7) compared to ERα‐ cell line (MDA‐MB‐231). Among the analogues synthesized, analogue 3d exhibited increased cytotoxicity. ERα silencing experiments confirmed the ERα selective nature of ligands. Transactivation assay on compound 3d indicated the down‐regulation of ERα luciferase reporter gene expression and induction of ERβ GFP in the treated cells. Cell cycle analysis revealed an increase in sub‐G0/G1 population on treatment with analogue 3d as compared to control. Similar to tamoxifen, 3d‐induced cell death is mediated through an increase in ROS as evidenced by change in roGFP ratio. Interestingly, the compound 3d induced mitochondrial trans‐membrane potential loss and caspase activation without indication of autophagy compared to tamoxifen that induced autophagy in the treated cells. Lack of significant autophagy and induction of ERβ signaling by the new compound place them as a better ERα antagonist.
- Subjects
CELL death; CELL cycle; CELL analysis; BINDING sites; REPORTER genes
- Publication
Chemical Biology & Drug Design, 2019, Vol 94, Issue 1, p1352
- ISSN
1747-0277
- Publication type
Article
- DOI
10.1111/cbdd.13510